Revision History
Claude Science · 5 revisions
Sizes are character counts of the article source. The signed number is the change from the previous revision.
Recent edit summaries
Detailed summaries recorded by editors. Generic maintenance summaries are omitted here; every recorded revision remains below. Dates describe the edit, not necessarily the event it covers.
- Correction: the AI for Science program dates from May 2025, not the Claude Science launch; protein-binder setup per model and 16/15 targets; LSVP wording; auto-retry sourcing; Yahoo date; QbitAI attribution; unsourced details and link targets (verifier V3)
Version 5 · Sep 27, 2026, 07:04 PM
- Correction: launch-day user table misstated Manifold Bio (it nominated targets, not medicine candidates) and Lecoq (about 10 reviews, not 10-plus); Amodei paraphrase 'only with their minds' was presented as a quote; unsupported claims removed (Claude Code GA/$2.5B revenue, $47B/$9B revenue, Series H, IPO 'at ~$965B' (Yahoo says last valued at $965B), Jumper role, Synthetic Sciences $1.9M raise); Modal credits are for select projects, not per project; Novo Nordisk/Allen Institute sourced to TechCrunch; GPT-Rosalind announced April 16 not 17; HN ref pointed to a different 'Open Science' project; Drake quote and cost wording fixed; '4x' skill claim attributed to 36Kr. Update: Windows version (Sep 10, 2026), still beta; Claude Team plan for scientists and expanded AI for Science program (Aug 27); models and safeguards incl. LSVP and Opus 5.5; GPT-Rosalind out of preview Sep 11; new Notable uses section (protein design, analytical chemistry, FlashPairformer optimization, ART).
Version 4 · Sep 27, 2026, 06:53 PM
- Added 6 contextual internal links
Version 3 · Jul 23, 2026, 04:06 PM
- Link OpenScience to its new page
Version 2 · Jul 14, 2026, 01:59 AM